NRGN and Alzheimer disease: Jia et al. found that concentrations of GAP43, NRGN, synaptosome-associated protein 25 (SNAP25), and synaptotagmin-1 in NDEs were significantly lower in AD patients compared to controls, and that their decline in NDEs reflects the synaptic loss that accompanies early AD.